T E Morgan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T E Morgan

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Clinical Research|January 12, 1979

A national policy for biomedical and behavioral research: position of the Association of American Medical CollegesR Berne, T Cooper, D Skinner, et al.

Experimental Neurology|November 1, 1992

Complement C1qB and C4 mRNAs responses to lesioning in rat brainG M Pasinetti, S A Johnson, I Rozovsky, et al.

Experimental Neurology|November 1, 1995

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stressT Oda, P Wals, H H Osterburg, et al.

Journal of Neurochemistry|November 10, 2001

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodiesM P Lambert, K L Viola, B A Chromy, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxinsM P Lambert, A K Barlow, B A Chromy, et al.

Translational Psychiatry|February 1, 2017

Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental modelsM Cacciottolo, X Wang, I Driscoll, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Clinical Research|January 12, 1979

A national policy for biomedical and behavioral research: position of the Association of American Medical CollegesR Berne, T Cooper, D Skinner, et al.

Experimental Neurology|November 1, 1992

Complement C1qB and C4 mRNAs responses to lesioning in rat brainG M Pasinetti, S A Johnson, I Rozovsky, et al.

Experimental Neurology|November 1, 1995

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stressT Oda, P Wals, H H Osterburg, et al.

Journal of Neurochemistry|November 10, 2001

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodiesM P Lambert, K L Viola, B A Chromy, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxinsM P Lambert, A K Barlow, B A Chromy, et al.

Translational Psychiatry|February 1, 2017

Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental modelsM Cacciottolo, X Wang, I Driscoll, et al.

Pageof 6